These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

518 related items for PubMed ID: 17378815

  • 1. Management of women with abnormal cervical cytology: treatment patterns and associated costs in England and Wales.
    Martin-Hirsch P, Rash B, Martin A, Standaert B.
    BJOG; 2007 Apr; 114(4):408-15. PubMed ID: 17378815
    [Abstract] [Full Text] [Related]

  • 2. Repeating cytology at initial colposcopy does not improve detection of high-grade abnormalities: a retrospective cohort study of 6595 women.
    Rieck GC, Bhaumik J, Beer HR, Leeson SC.
    Gynecol Oncol; 2006 May; 101(2):228-33. PubMed ID: 16325241
    [Abstract] [Full Text] [Related]

  • 3. Analysis of outcome in women with borderline glandular change on cervical cytology.
    Jadoon BA, Kehoe S, Romain K, Clelland C, Sundar SS.
    Eur J Obstet Gynecol Reprod Biol; 2009 Nov; 147(1):83-5. PubMed ID: 19740591
    [Abstract] [Full Text] [Related]

  • 4. High-grade cervical abnormalities and screening intervals in New South Wales, Australia.
    Schindeler S, Morrell S, Zuo Y, Baker D.
    J Med Screen; 2008 Nov; 15(1):36-43. PubMed ID: 18416954
    [Abstract] [Full Text] [Related]

  • 5. Cervical cancer screening in a rural population of Zimbabwe.
    Thistle PJ, Chirenje ZM.
    Cent Afr J Med; 1997 Sep; 43(9):246-51. PubMed ID: 9509642
    [Abstract] [Full Text] [Related]

  • 6. Cost-effectiveness of adding human papilloma virus testing to a managed care cervical cancer screening program.
    Lonky NM, Hunter MI, Sadeghi M, Edwards G, Bajamundi K, Monk BJ.
    J Low Genit Tract Dis; 2007 Oct; 11(4):258-64. PubMed ID: 17917570
    [Abstract] [Full Text] [Related]

  • 7. [Cervical cancer screening and associated treatment costs in France].
    Bergeron C, Breugelmans JG, Bouée S, Lorans C, Bénard S, Rémy V.
    Gynecol Obstet Fertil; 2006 Nov; 34(11):1036-42. PubMed ID: 17070085
    [Abstract] [Full Text] [Related]

  • 8. European guidelines for quality assurance in cervical cancer screening: recommendations for clinical management of abnormal cervical cytology, part 1.
    Jordan J, Arbyn M, Martin-Hirsch P, Schenck U, Baldauf JJ, Da Silva D, Anttila A, Nieminen P, Prendiville W.
    Cytopathology; 2008 Dec; 19(6):342-54. PubMed ID: 19040546
    [Abstract] [Full Text] [Related]

  • 9. A retrospective study of cervical screening in women under 25 years (2005-2009).
    Ali AA, Richardson D, Hill N.
    Arch Gynecol Obstet; 2013 Apr; 287(4):765-9. PubMed ID: 23183714
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Is a liquid-based cytology more sensitive than a conventional Pap smear?
    Sigurdsson K.
    Cytopathology; 2013 Aug; 24(4):254-63. PubMed ID: 23331613
    [Abstract] [Full Text] [Related]

  • 12. [Are analyses of cytological cervix smears from young women more harmful than beneficial?].
    Skjeldestad FE, Hagen B, Hagmar B, Iversen OE, Juvkam KH, Steen R, Thoresen S, Hareide B.
    Tidsskr Nor Laegeforen; 2007 Jun 28; 127(13):1782-5. PubMed ID: 17599128
    [Abstract] [Full Text] [Related]

  • 13. The agreement between self-reported cervical smear abnormalities and screening programme records.
    Canfell K, Beral V, Green J, Cameron R, Baker K, Brown A.
    J Med Screen; 2006 Jun 28; 13(2):72-5. PubMed ID: 16792828
    [Abstract] [Full Text] [Related]

  • 14. Low-cost technology for screening uterine cervical cancer.
    Parashari A, Singh V, Sehgal A, Satyanarayana L, Sodhani P, Gupta MM.
    Bull World Health Organ; 2000 Jun 28; 78(8):964-7. PubMed ID: 10994279
    [Abstract] [Full Text] [Related]

  • 15. Combined cytology and colposcopy to screen for cervical cancer in pregnancy.
    Guerra B, De Simone P, Gabrielli S, Falco P, Montanari G, Bovicelli L.
    J Reprod Med; 1998 Aug 28; 43(8):647-53. PubMed ID: 9749413
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Cost analysis of colposcopy for abnormal cytology in post-treatment surveillance for cervical cancer.
    Tergas AI, Havrilesky LJ, Fader AN, Guntupalli SR, Huh WK, Massad LS, Rimel BJ.
    Gynecol Oncol; 2013 Sep 28; 130(3):421-5. PubMed ID: 23747836
    [Abstract] [Full Text] [Related]

  • 19. Early detection of precursors of cervical cancer with cervical cytology and visual inspection of cervix with acetic Acid.
    Dhaubhadel P, Vaidya A, Choudhary P.
    JNMA J Nepal Med Assoc; 2008 Sep 28; 47(170):71-6. PubMed ID: 18709035
    [Abstract] [Full Text] [Related]

  • 20. MAVARIC - a comparison of automation-assisted and manual cervical screening: a randomised controlled trial.
    Kitchener HC, Blanks R, Cubie H, Desai M, Dunn G, Legood R, Gray A, Sadique Z, Moss S, MAVARIC Trial Study Group.
    Health Technol Assess; 2011 Jan 28; 15(3):iii-iv, ix-xi, 1-170. PubMed ID: 21266159
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.